XML 18 R7.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Mar. 31, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Dec. 31, 2023
Operating activities                
Net loss $ (4,794,215) $ (6,878,601) $ (1,649,843) $ (6,728,737) $ (25,241,278) $ (12,327,595)    
Adjustments to reconcile net loss to net cash used in operating activities                
Depreciation and amortization         245,796 254,275    
Stock-based compensation         814,305 1,991,884    
Amortization of discount on debt and promissory notes         166,611 24,167    
Change in fair value of warrants/investment rights liability         (673,899) (2,642,424)    
Change in fair value of convertible notes 112,367   0   60,663 0    
Change in fair value of derivative liability         0 3,626    
Fair value of warrants issued for cryptocurrency strategy consulting services         8,194,000 0    
Loss on warrants issuance         0 305,065    
Provision for credit losses         990,105 0    
Noncash lease expense         592,386 223,892    
Change in operating assets and liabilities                
Accounts receivable         48,838 56,361    
Inventory         336,785 230,712    
Prepaid expenses and other assets         (1,542,242) 728,999    
Accounts payable         1,062,150 490,130    
Accrued expenses and other liabilities         2,146,135 (1,524,707)    
Deferred revenue         451,661 (57,207)    
Net cash used in operating activities         (12,347,984) (12,242,822) $ (15,700,000) $ (21,300,000)
Investing activities                
Acquisition         (340,200) 0    
Purchase of property and equipment         (57,099) (54,630)    
Net cash used in investing activities         (397,299) (54,630)    
Financing activities                
Proceeds from exercise of warrants         2,083,900 173,027    
Proceeds from debt and promissory notes obligations         8,972,199 2,565,500    
Repayment of debt and promissory notes obligations         (3,401,943) (161,929)    
Proceeds from common stock offering, including pre-funded warrants, net of issuance costs         5,509,874 8,516,741    
Payment of finance lease obligations         (6,835) (7,816)    
Proceeds from issuance of Class B units         150,000 0    
Net cash provided in financing activities         13,307,195 11,085,523    
Effect of exchange rate on cash         6,006 2,514    
Net increase (decrease) in cash and restricted cash         567,918 (1,209,415)    
Cash and restricted cash at beginning of year   $ 691,497   $ 2,014,660 691,497 2,014,660 2,014,660  
Cash and restricted cash at end of period $ 1,259,415   $ 805,245   1,259,415 805,245 $ 691,497 $ 2,014,660
Supplemental Disclosure of cash information:                
Cash paid for interest         1,096,650 193,322    
Supplemental Disclosure of Noncash Investing and Financing Activities:                
Conversion of Notes and accrued interest to common shares         10,132,855 0    
Payment of Promissory with Contingent Receivable         283,578 0    
Issuance of preferred class A units for acquisition         $ 166,698 $ 0